Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Urinary RhoA, NGF, and BDNF Levels in Diagnosis and Follow-up in Children With Overactive Bladder and Vitamin D Deficiency.

NCT07513363 is registered in ClinicalTrials.gov with Tarik Emre Sener as lead sponsor.

NCT NCT07513363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07513363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Urinary RhoA, NGF, and BDNF Levels in Diagnosis and Follow-up in Children With Overactive Bladder and Vitamin D Deficiency.
Lead sponsor
Tarik Emre Sener
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
January 1, 2027
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, vitamin d deficiency